Our present findings in both WT and R6/2 mice point to the brain-penetrating and mitohormesis-inducing potential of the Prodh suicide inhibitor, N-PPG, and provide new rationale and application insights compelling its further preclinical evaluation in other models of human neurodegenerative diseases characterized by loss of mitochondrial proteostasis. Here, PRODH is linked to neurodegenerative disease.